Evolus, Inc. Made Big Gain
Wed, Jan 26, 2022 at 05:30 PM
Evolus, Inc. (EOLS:NASDAQ) soared at $6.59, representing a gain of 17.3%. The stock got featured on our News Catalysts scanner on Wed, Jan 26, 2022 at 10:08 AM in the 'BIOTECH' category. From Wed, Jan 12, 2022, the stock recorded 62.50% Up Days and 44.44% Green Days
The share price of the company has been moving sideways in recent weeks.
About Evolus, Inc. (EOLS:NASDAQ)
Evolus Inc is engaged in providing physicians and their patients with expanded choices in medical aesthetic treatments and procedures. Its product candidate is an injectable formulation of a 900 kDa Botulinum toxin Type A complex.
Top 10 Gainers:
- OmniLit Acquisition Corp. (OLIT:NASDAQ), 100%
- Ebang International Holdings Inc. (EBON:NASDAQ), 35.44%
- Eros STX Global Corporation A (ESGC:NYSE), 30.24%
- Sierra Oncology, Inc. (SRRA:NASDAQ), 26.28%
- K12 Inc. (LRN:NYSE), 25.04%
- Larimar Therapeutics Inc. (LRMR:NASDAQ), 21.25%
- Groupon, Inc. (GRPN:NASDAQ), 20.02%
- Huadi International Group Co. Ltd. (HUDI:NASDAQ), 19.81%
- Rani Therapeutics Holdings Inc. (RANI:NASDAQ), 19.59%
- Evolus, Inc. (EOLS:NASDAQ), 17.26%